Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer
- 1 January 2015
- book chapter
- Published by Springer Nature
- Vol. 867, 263-275
Abstract
The pursuit of minimally invasive biomarkers is a challenging but exciting area of research. Clearly, such markers would need to be sensitive and specific enough to aid in the detection of breast cancer at an early stage, would monitor progression of the disease, and could predict the individual patient’s response to treatment. Unfortunately, to date, markers with such characteristics have not made it to the clinic for breast cancer. Past years, many studies indicated that the non-coding part of our genome (the so called ‘junk’ DNA), may be an ideal source for these biomarkers. In this chapter, the potential use of microRNAs and long non-coding RNAs as biomarkers will be discussed.Keywords
This publication has 116 references indexed in Scilit:
- Extracellular microRNA: A new source of biomarkersMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2011
- Long Noncoding RNAs with Enhancer-like Function in Human CellsCell, 2010
- MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmationInternational journal of legal medicine, 2010
- RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer MetastasisCell, 2009
- Identification of forensically relevant body fluids using a panel of differentially expressed microRNAsAnalytical Biochemistry, 2009
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- Functional Demarcation of Active and Silent Chromatin Domains in Human HOX Loci by Noncoding RNAsCell, 2007
- Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA TargetsCell, 2005
- Molecular Evolution of a MicroRNA ClusterJournal of Molecular Biology, 2004
- Prediction of Mammalian MicroRNA TargetsCell, 2003